Already a subscriber? 

MADCAD.com Free Trial
Sign up for a 3 day free trial to explore the MADCAD.com interface, PLUS access the
2009 International Building Code to see how it all works.
If you like to setup a quick demo, let us know at support@madcad.com
or +1 800.798.9296 and we will be happy to schedule a webinar for you.
Security check
Please login to your personal account to use this feature.
Please login to your authorized staff account to use this feature.
Are you sure you want to empty the cart?

BS EN 17272:2020+A1:2025 Chemical disinfectants and antiseptics — Methods of airborne room disinfection by automated process — Determination of bactericidal, mycobactericidal, sporicidal, fungicidal, yeasticidal, virucidal and phagocidal activities, 2026
- undefined
- European foreword
- Introduction
- 1 Scope
- 2 Normative references
- 3 Terms and definitions
- 4 Requirements [Go to Page]
- 4.1 Efficacy tests
- 4.2 Distribution tests
- 5 Test method [Go to Page]
- 5.1 Principle [Go to Page]
- 5.1.1 Preliminary test to validate absence of residual effect
- 5.1.2 Efficacy test
- 5.1.3 Distribution test
- 5.2 Materials and reagents [Go to Page]
- 5.2.1 Test organisms
- 5.2.2 Culture media and reagents [Go to Page]
- 5.2.2.1 General
- 5.2.2.2 Culture media for bacteria, mycobacteria, spores, fungal spores and yeasts [Go to Page]
- 5.2.2.2.1 Water
- 5.2.2.2.2 Agar for bacterial counts (Tryptone Soya Agar: TSA)
- 5.2.2.2.3 Reconstituted milk for use with sensitive test organisms
- 5.2.2.2.4 Agar for mycobacteria (refer to 5.2.1.7. and 5.2.1.8)
- 5.2.2.2.5 Medium for spores (refer to 5.2.1.9)
- 5.2.2.2.6 Malt extract agar (MEA)
- 5.2.2.2.7 Diluent for microbial suspensions [Go to Page]
- !Bacteria, yeast, fungi and spores"
- Mycobacteria: Tryptone salt !(5.2.2.2.7)" or distilled water (5.2.2.2.1).
- 5.2.2.2.8 Liquid for test organism recovery and rinsing liquid for membrane filtration
- 5.2.2.3 Culture media and reagents for preparation of virus (test organisms 5.2.1.12 to 5.2.1.14.)
- 5.2.2.4 Culture media and reagents for preparation of bacteriophages (test organisms 5.2.1.15 to 5.2.1.16.) [Go to Page]
- 5.2.2.4.1 M17 culture broth
- 5.2.2.4.2 M17 agar (underlay agar)
- 5.2.2.4.3 Overlay agar (surface agar, soft agar)
- 5.2.2.4.4 Bacteriophage diluent (based on Ringer's solution diluted to 1/4)
- 5.2.2.4.5 SM buffer
- 5.2.2.4.6 CaCl2 stock solutions (1 mol/l and 0,05 mol/l)
- 5.2.2.4.7 Lactic acid solution (10 % volume fraction)
- 5.2.2.4.8 Bacteriophage and virus recovery and rinsing liquid
- 5.2.2.5 Interfering substance (See Annex C)
- 5.2.3 Carriers [Go to Page]
- 5.2.3.1 General
- 5.2.3.2 Obligatory carriers
- 5.2.3.3 Additional carriers
- 5.3 Apparatus and glassware [Go to Page]
- 5.3.1 General
- 5.3.2 Usual microbiological laboratory equipment, and in particular, the following:
- 5.4 Preparation and counting of test suspensions [Go to Page]
- 5.4.1 Preparation of test suspensions (bacteria, spores, fungal spores, yeasts, mycobacteria) [Go to Page]
- 5.4.1.1 Preservation of test organisms and stock cultures
- 5.4.1.2 Working culture of test organisms [Go to Page]
- 5.4.1.2.1 General
- 5.4.1.2.2 Bacterial suspensions
- 5.4.1.2.3 Mycobacterial suspensions
- 5.4.1.2.4 Spore suspensions
- 5.4.1.2.5 Fungal spores and yeasts
- 5.4.1.3 Preparation of suspensions in interfering substance [Go to Page]
- 5.4.1.3.1 Bacteria (see 5.2.1.1 to 5.2.1.6)
- 5.4.1.3.2 !Mycobacterium avium and Mycobacterium terrae (refer to 5.2.1.7 and 5.2.1.8)
- 5.4.1.3.3 Bacterial spores (refer to 5.2.1.9)
- 5.4.1.3.4 Candida albicans (refer to 5.2.1.10)
- 5.4.1.3.5 Aspergillus brasiliensis (refer to 5.2.1.11)
- Figure 1 — View of conidiospores using an optical microscope — presence of smooth and spiny spores (unacceptable suspension)
- Figure 2 —View of conidiospores using an optical microscope — high concentration of characteristic mature spiny spores (acceptable suspension) [Go to Page]
- 5.4.1.4 Counting of suspensions prepared in interfering substance [Go to Page]
- 5.4.1.4.1 Bacteria
- 5.4.1.4.2 Mycobacteria
- 5.4.1.4.3 Bacterial spores
- 5.4.1.4.4 Fungal spores and yeasts
- 5.4.2 Preparation and counting of viral suspensions [Go to Page]
- 5.4.2.1 Viral stock suspension
- 5.4.2.2 Viral test suspension
- 5.4.2.3 Infectivity test [Go to Page]
- 5.4.2.3.1 Virus titre on suspended cells in microtitration plates
- 5.4.2.3.2 Virus titre on pre-established mono-cellular lawns in microtitration plates
- 5.4.2.3.3 Plaque assay method
- 5.4.3 Preparation and counting of bacteriophage test suspensions [Go to Page]
- 5.4.3.1 Host bacteria stock culture
- 5.4.3.2 Host bacteria working culture
- 5.4.3.3 Bacteriophage stock suspension
- 5.4.3.4 High-titre bacteriophage suspension
- 5.4.3.5 Preparation of bacteriophage suspension
- 5.4.3.6 Preparation of bacteriophages in interfering substance
- 5.5 Procedure for evaluating the automated airborne disinfection process activity [Go to Page]
- 5.5.1 Procedure for evaluating the process activity according to conditions of use furnished by the manufacturer (bacteria, mycobacteria, spores, fungal spores, yeasts, bacteriophages). [Go to Page]
- 5.5.1.1 Experimental conditions (obligatory, supplementary obligatory and additional)
- Table 1 — Manufacturers' intended use volume claims [Go to Page]
- 5.5.1.2 Survival controls of test organisms on carriers (efficacy and distribution tests) [Go to Page]
- 5.5.1.2.1 General
- 5.5.1.2.2 Contamination and drying of the control-carriers
- 5.5.1.2.3 Counting of the control-carriers
- 5.5.1.2.4 Bacteriophage counts on the control-carriers
- 5.5.1.3 Preliminary test to validate absence of residual effect (efficacy test and distribution tests) [Go to Page]
- 5.5.1.3.1 Recovering product residues on the carrier and testing for any potential antimicrobial effect
- 5.5.1.3.2 Screening for an inhibitory effect in the agar medium
- 5.5.1.3.3 Screening for an inhibitory effect in filter membranes
- 5.5.1.3.4 Screening for a carrier-related inhibitory effect in the agar medium
- 5.5.1.4 Efficacy and distribution tests [Go to Page]
- 5.5.1.4.1 Contamination of the test-carriers
- 5.5.1.4.2 Exposure of the test-carriers to the automated airborne disinfection process under test
- 5.5.1.4.3 Counting of bacteria, mycobacteria, bacterial spores, yeasts, fungal spores, and bacteriophages recovered
- 5.5.1.4.4 Incubation and counting of the test mixture
- 5.5.2 Virucidal activity tests [Go to Page]
- 5.5.2.1 General
- 5.5.2.2 Preliminary test to validate absence of residual effect [Go to Page]
- 5.5.2.2.1 Recovering product residues on the carrier and testing for any potential virucidal effect
- 5.5.2.2.2 !Cytotoxicity
- 5.5.2.2.3 Susceptibility of cells to viruses
- 5.5.2.2.4 Evaluating inhibition of product activity
- 5.5.2.3 Efficacy test [Go to Page]
- 5.5.2.3.1 Contamination of the carriers
- 5.5.2.3.2 Exposure of the test-carriers to automated airborne disinfection process
- 5.5.2.3.3 Determination of viral titre after exposure
- 5.5.2.4 Calculation and expression of results
- 5.5.3 Procedure for evaluating the mycobactericidal activity [Go to Page]
- 5.5.3.1 General
- 5.5.3.2 Contamination of the carriers
- 5.5.3.3 Exposure of the test-carriers to the product under test
- 5.5.3.4 Counts on the carriers
- 5.6 !Bacteria, mycobacteria, bacterial spores, yeasts, fungal spores and bacteriophages" [Go to Page]
- 5.6.1 General
- 5.6.2 Colony counting and limit thresholds
- 5.6.3 Determining number of test organisms N in bacterial, mycobacterial, bacterial spores, yeasts, fungal spores and bacteriophage suspensions (refer to 5.4)
- 5.6.4 Determining number of microorganisms T on control-carriers (refer to 5.5.1.2)
- 5.6.5 Determining values obtained in the preliminary test (refer to 5.5.1.3)
- 5.6.6 Determining the number of test organisms and plaques on test-carriers post- exposure and the reduction R (refer to 5.5.1.4.3)
- 5.7 Interpretation of results
- 5.8 Test report
- Table 2 — RESULTS: example for an automated process
- Annex A (normative) Summary of test requirements
- A.1 Efficacy tests
- Table A.1 — Efficacy tests
- A.2 Distribution tests
- Table A.2 — Distribution tests
- Annex B (normative) Distance between diffusion device and test-carriers (efficacy test)
- Table B.1 — Values applied with a tolerance of ± 10 % for volumes between 30 m3 and 150 m3
- Annex C (normative) Interfering substance
- Table C.1 — Conditions for products
- Annex D (normative) Preparation of spore stock suspensions of Bacillus subtilis
- D.1 Material and reagents
- D.1.1 Tryptone Glucose Broth (TGB):
- D.1.2 Yeast extract Agar (MYA):
- D.1.3 Centrifuge, capable of 10 000 gN acceleration
- D.2 Preparation of Bacillus spore stock suspensions
- Annex E (normative) Graphical representation of the test procedure (efficacy test)
- Figure E.1 — Control-carriers
- Figure E.2 — Preliminary test
- Figure E.3 — Preliminary test – Recovery of product residues
- Figure E.4 — Preliminary test – Exposure and recovery
- Figure E.5 — Scheme of a test room !(distribution test)"
- Figure E.6 — Scheme 1 of an example carrier position !(distribution test)"
- Figure E.7 — Scheme 2 of an example carrier position (not to scale) !(distribution test)"
- Bibliography [Go to Page]